Houttuynia cordata targets the beginning stage of herpes simplex virus infection

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Hung, Pei Yun ^a   Ho, Bing Ching ^a,b   Lee, Szu Yuan ^a   Chang, Sui Yuan ^a,c   Kao, Chuan Liang ^a,c   Lee, Shoei Sheng ^b   Lee, Chun Nan ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHLOROGENIC ACID; GLYCOPROTEIN D; HOUTTUYNIA CORDATA EXTRACT; HOUTTUYNIA CORDATA WATER EXTRACT; HYPERIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISOQUERCITRIN; QUERCETIN; QUERCITRIN; RUTOSIDE; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; GLYCOPROTEIN D, HUMAN HERPESVIRUS 1; PLANT EXTRACT; VIRUS ENVELOPE PROTEIN; WATER;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HOUTTUYNIA CORDATA; HUMAN; HUMAN CELL; IE GENE; MOLECULAR MECHANICS; NONHUMAN; TRANSCRIPTION INITIATION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENE; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEAT; HOUTTUYNIA; ISOLATION AND PURIFICATION; METABOLISM; PHYSIOLOGY; VIRION;

HOUTTUYNIA CORDATA; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; SIMPLEXVIRUS;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG RESISTANCE, VIRAL; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; HOT TEMPERATURE; HOUTTUYNIA; HUMANS; NF-KAPPA B; PLANT EXTRACTS; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS INTERNALIZATION; VIRUS REPLICATION; WATER;

EID: 84922309687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115475     Document Type: Article

References (63)

1. Baringer JR (1974) Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med 291: 828-830. doi: 10.1056/NEJM197410172911606
2. Farooq AV, Shukla D (2012) Herpes simplex epithelial and stromal keratitis: an epidemiologic update. Surv Ophthalmol 57: 448-462. doi: 10.1016/j.survophthal.2012.01.0052
3. Kupila L, Vuorinen T, Vainionpaa R, Hukkanen V, Marttila RJ, et al. (2006) Etiology of aseptic meningitis and encephalitis in an adult population. Neurology 66: 75-80. doi: 10.1212/01.wnl.0000191407. 81333.000
4. Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, et al. (2006) Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296: 964-973. doi: 10.1001/jama.296.8. 9646
5. Epstein JB, Scully C (1991) Herpes simplex virus in immunocompromised patients: growing evidence of drug resistance. Oral Surg Oral Med Oral Pathol 72: 47-50. doi: 10.1016/0030-4220(91)90188-I
6. Mommeja-Marin H, Lafaurie M, Scieux C, Galicier L, Oksenhendler E, et al. (2003) Herpes simplex virus type 2 as a cause of severe meningitis in immunocompromised adults. Clin Infect Dis 37: 1527-1533. doi: 10.1086/3795206
7. Balfour HH Jr., (1983) Resistance of herpes simplex to acyclovir. Ann Intern Med 98: 404-406. doi: 10. 7326/0003-4819-98-3-404
8. Bevilacqua F, Marcello A, Toni M, Zavattoni M, Cusini M, et al. (1991) Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient. J Acquir Immune Defic Syndr 4: 967-969
9. McLaren C, Chen MS, Ghazzouli I, Saral R, Burns WH (1985) Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir. Antimicrob Agents Chemother 28: 740-744. doi: 10.1128/AAC.28.6.740
10. Wutzler P (1997) Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology 40: 343-356. doi: 10.1159/000150567
11. Piret J, Boivin G (2011) Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management. Antimicrob Agents Chemother 55: 459-472. doi: 10.1128/AAC.00615- 109
12. Erlich KS, Mills J, Chatis P, Mertz GJ, Busch DF, et al. (1989) Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome. N Engl J Med 320: 293-296. doi: 10.1056/NEJM198902023200506
13. Spear PG (2004) Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol 6: 401-410. doi: 10.1111/j.1462-5822.2004.00389.x1
14. Herold BC, WuDunn D, Soltys N, Spear PG (1991) Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol 65: 1090-1098
15. Moerdyk-Schauwecker M, Stein DA, Eide K, Blouch RE, Bildfell R, et al. (2009) Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27. Antiviral Res 84: 131-141. doi: 10.1016/j.antiviral.2009.07.0206
16. Knopf CW (2000) Molecular mechanisms of replication of herpes simplex virus 1. Acta Virol 44: 289-307
17. Amici C, Rossi A, Costanzo A, Ciafre S, Marinari B, et al. (2006) Herpes simplex virus disrupts NF-kappaB regulation by blocking its recruitment on the IkappaBalpha promoter and directing the factor on viral genes. J Biol Chem 281: 7110-7117. doi: 10.1074/jbc.M5123662004
18. Chen SH, Yao HW, Chen IT, Shieh B, Li C (2008) Suppression of transcription factor early growth response 1 reduces herpes simplex virus lethality in mice. J Clin Invest 118: 3470-3477. doi: 10.1172/JCI351142
19. Jones KA, Tjian R (1985) Sp1 binds to promoter sequences and activates herpes simplex virus 'immediate- early' gene transcription in vitro. Nature 317: 179-182. doi: 10.1038/317179a0
20. Newman DJ, Cragg GM, Snader KM (2003) Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037. doi: 10.1021/np030096l0
21. Marcelletti JF (2002) Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs. Antiviral Res 56: 153-166. doi: 10.1016/S0166-3542(02)00105-51
22. Tatti S, Stockfleth E, Beutner KR, Tawfik H, Elsasser U, et al. (2009) Polyphenon E(R): a new treatment for external anogenital warts. Br J Dermatol. doi: 10.1111/j.1365-2133.2009.09375.x0
23. Ng LT, Yen FL, Liao CW, Lin CC (2007) Protective effect of Houttuynia cordata extract on bleomycininduced pulmonary fibrosis in rats. Am J Chin Med 35: 465-475. doi: 10.1142/S0192415X07004989 5
24. Tutupalli LV, Chaubal MG (1975) Saururaceae. V. Composition of essential oil from foliage of Houttuynia cordata and chemo systematics of Saururaceae. Lloydia 38: 92-96
25. Choi HJ, Song JH, Park KS, Kwon DH (2009) Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication. Eur J Pharm Sci 37: 329-333. doi: 10.1016/j.ejps.2009.03.0023
26. Lau KM, Lee KM, Koon CM, Cheung CS, Lau CP, et al. (2008) Immunomodulatory and anti-SARS activities of Houttuynia cordata. J Ethnopharmacol 118: 79-85. doi: 10.1016/j.jep.2008.03.018 3
27. Chen X, Wang Z, Yang Z, Wang J, Xu Y, et al. (2011) Houttuynia cordata blocks HSV infection through inhibition of NF-kappaB activation. Antiviral Res 92: 341-345. doi: 10.1016/j.antiviral.2011.09.005 5
28. Chiang LC, Chang JS, Chen CC, Ng LT, Lin CC (2003) Anti-Herpes simplex virus activity of Bidens pilosa and Houttuynia cordata. Am J Chin Med 31: 355-362. doi: 10.1142/S0192415X03001090 7
29. Hayashi K, Kamiya M, Hayashi T (1995) Virucidal effects of the steam distillate from Houttuynia cordata and its components on HSV-1, influenza virus, and HIV. Planta Med 61: 237-241. doi: 10.1055/s- 2006-958063
30. Chen YY, Liu JF, Chen CM, Chao PY, Chang TJ (2003) A study of the antioxidative and antimutagenic effects of Houttuynia cordata Thunb. using an oxidized frying oil-fed model. J Nutr Sci Vitaminol (Tokyo) 49: 327-333. doi: 10.3177/jnsv.49.3277
31. Lu HM, Liang YZ, Yi LZ, Wu XJ (2006) Anti-inflammatory effect of Houttuynia cordata injection. J Ethnopharmacol 104: 245-249. doi: 10.1016/j.jep.2005.09.0128
32. Farah A, Monteiro M, Donangelo CM, Lafay S (2008) Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 138: 2309-2315. doi: 10.3945/jn.108.0955540
33. Meng J, Dong XP, Jiang ZH, Leung SY, Zhao ZZ (2006) [Study on chemical constituents of flavonoids in fresh herb of Houttuynia cordata]. Zhongguo Zhong Yao Za Zhi 31: 1335-1337
34. Su CT, Hsu JT, Hsieh HP, Lin PH, Chen TC, et al. (2008) Anti-HSV activity of digitoxin and its possible mechanisms. Antiviral Res 79: 62-70. doi: 10.1016/j.antiviral.2008.01.1562
35. Melancon JM, Fulmer PA, Kousoulas KG (2007) The herpes simplex virus UL20 protein functions in glycoprotein K (gK) intracellular transport and virus-induced cell fusion are independent of UL20 functions in cytoplasmic virion envelopment. Virol J 4: 120. doi: 10.1186/1743-422X-4-120
36. Ottosen S, Herrera FJ, Doroghazi JR, Hull A, Mittal S, et al. (2006) Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites. Virology 345: 468-481. doi: 10.1016/j.virol.2005.10.0114
37. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, et al. (2004) Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virol 78: 5147-5156. doi: 10. 1128/JVI.78.10.5147-5156.20047
38. Montgomery RI, Warner MS, Lum BJ, Spear PG (1996) Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87: 427-436. doi: 10.1016/S0092-8674 (00)81363-X
39. Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, et al. (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99: 13-22. doi: 10.1016/S0092-8674(00)80058-6
40. Warner MS, Geraghty RJ, Martinez WM, Montgomery RI, Whitbeck JC, et al. (1998) A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246: 179-189. doi: 10. 1006/viro.1998.9218
41. Meng J, Leung KS, Jiang Z, Dong X, Zhao Z, et al. (2005) Establishment of HPLC-DAD-MS fingerprint of fresh Houttuynia cordata. Chem Pharm Bull (Tokyo) 53: 1604-1609. doi: 10.1248/cpb.53.1604
42. Fuller AO, Lee WC (1992) Herpes simplex virus type 1 entry through a cascade of virus-cell interactions requires different roles of gD and gH in penetration. J Virol 66: 5002-5012
43. Johnson DC, Burke RL, Gregory T (1990) Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J Virol 64: 2569-2576
44. Johnson DC, LigasMW(1988) Herpes simplex viruses lacking glycoprotein D are unable to inhibit virus penetration: quantitative evidence for virus-specific cell surface receptors. J Virol 62: 4605-4612
45. Lee WC, Fuller AO (1993) Herpes simplex virus type 1 and pseudorabies virus bind to a common saturable receptor on Vero cells that is not heparan sulfate. J Virol 67: 5088-5097
46. Everett RD (1984) Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J 3: 3135-3141
47. Gelman IH, Silverstein S (1985) Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A 82: 5265-5269. doi: 10.1073/pnas.82.16.5265
48. Sacks WR, Schaffer PA (1987) Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol 61: 829-839
49. Brasier AR (2006) The NF-kappaB regulatory network. Cardiovasc Toxicol 6: 111-130. doi: 10.1385/CT:6:2:1119
50. Taddeo B, Luo TR, Zhang W, Roizman B (2003) Activation of NF-kappaB in cells productively infected with HSV-1 depends on activated protein kinase R and plays no apparent role in blocking apoptosis. Proc Natl Acad Sci U S A 100: 12408-12413. doi: 10.1073/pnas.20349521005
51. Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ (2006) Resveratrol suppresses nuclear factorkappaB in herpes simplex virus infected cells. Antiviral Res 72: 242-251. doi: 10.1016/j.antiviral.2006. 06.0115
52. Abou-Karam M, Shier WT (1992) Isolation and characterization of an antiviral flavonoid from Waldsteinia fragarioides. J Nat Prod 55: 1525-1527. doi: 10.1021/np50088a022
53. Lyu SY, Rhim JY, Park WB (2005) Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res 28: 1293-1301. doi: 10.1007/BF029782158
54. Tao J, Hu Q, Yang J, Li R, Li X, et al. (2007) In vitro anti-HIV and-HSV activity and safety of sodium rutin sulfate as a microbicide candidate. Antiviral Res 75: 227-233. doi: 10.1016/j.antiviral.2007.03.008
55. Jo HY, Kim Y, Nam SY, Lee BJ, Kim YB, et al. (2008) The inhibitory effect of quercitrin gallate on iNOS expression induced by lipopolysaccharide in Balb/c mice. J Vet Sci 9: 267-272. doi: 10.4142/jvs.2008. 9.3.2676
56. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 24: 1680-1684
57. Shih CM, Lin H, Liang YC, Lee WS, Bi WF, et al. (2004) Concentration-dependent differential effects of quercetin on rat aortic smooth muscle cells. Eur J Pharmacol 496: 41-48. doi: 10.1016/j.ejphar.2004. 06.0163
58. Xu GH, Ryoo IJ, Kim YH, Choo SJ, Yoo ID (2009) Free radical scavenging and antielastase activities of flavonoids from the fruits of Thuja orientalis. Arch Pharm Res 32: 275-282. doi: 10.1007/s12272-009- 1233-y9
59. Liu ZM, Yang YS, Wang XL, Wen RX (2006) [Recent progress on anti-HIV research of traditional Chinese medicine and components]. Zhongguo Zhong Yao Za Zhi 31: 1753-1758
60. Nguyen TT, Woo HJ, Kang HK, Nguyen VD, Kim YM, et al. (2012) Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. Biotechnol Lett 34: 831-838. doi: 10. 1007/s10529-011-0845-87
61. Savov VM, Galabov AS, Tantcheva LP, Mileva MM, Pavlova EL, et al. (2006) Effects of rutin and quercetin on monooxygenase activities in experimental influenza virus infection. Exp Toxicol Pathol 58: 59-64. doi: 10.1016/j.etp.2006.05.0026
62. Kavouras JH, Prandovszky E, Valyi-Nagy K, Kovacs SK, Tiwari V, et al. (2007) Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures. J Neurovirol 13: 416-425. doi: 10.1080/13550280701460573
63. Kim JC, Choi SH, Kim JK, Kim Y, Kim HJ, et al. (2008) [Herpes simplex virus type 1 ICP27 induces apoptotic cell death by increasing intracellular reactive oxygen species]. Mol Biol (Mosk) 42: 470-477. doi: 10.1134/S00268933080300965